Amylyx Pharmaceuticals, Inc (AMLX) insider trading
Every open-market stock purchase and sale by Amylyx Pharmaceuticals, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $152K over the last 12 months (2 buys).
- Insiders sold $5.8M over the last 12 months (16 sales).
- Last insider buy: Karen Firestone (Insider), $51.3K, 4 months ago.
Last 12 months: insiders bought $152K (2 buys) and sold $5.8M (16 sales). Last close $13.32 on Jun 4, 2026.
Recent AMLX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 4, 2026 | Karen Firestone (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Bernhardt G Zeiher (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Daphne Quimi (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | George M Milne Jr (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Paul R. Fonteyne (Insider) | Bought (not open market) | — |
| May 21, 2026 | Karen Firestone (Insider) | Bought | $51.3K |
| Mar 5, 2026 | James M Frates (CFO) | Bought (not open market) | — |
| Mar 5, 2026 | Justin B. Klee (CEO) | Bought (not open market) | — |
| Mar 5, 2026 | James M Frates (CFO) | Bought (not open market) | — |
| Mar 5, 2026 | Joshua B Cohen (CEO) | Bought (not open market) | — |
| Mar 5, 2026 | Gina Mazzariello (C-suite exec) | Bought (not open market) | — |
| Mar 5, 2026 | Joshua B Cohen (CEO) | Bought (not open market) | — |
| Mar 5, 2026 | Camille L Bedrosian (C-suite exec) | Bought (not open market) | — |
| Mar 5, 2026 | Camille L Bedrosian (C-suite exec) | Bought (not open market) | — |
| Mar 5, 2026 | Gina Mazzariello (C-suite exec) | Bought (not open market) | — |
| Mar 5, 2026 | Justin B. Klee (CEO) | Bought (not open market) | — |
| Mar 2, 2026 | Joshua B Cohen (CEO) | Sold | $424K |
| Mar 2, 2026 | Justin B. Klee (CEO) | Sold | $424K |
| Mar 2, 2026 | James M Frates (CFO) | Sold | $115K |
| Mar 2, 2026 | Gina Mazzariello (C-suite exec) | Sold | $99.4K |
| Mar 2, 2026 | Camille L Bedrosian (C-suite exec) | Sold | $94.2K |
| Feb 23, 2026 | Gina Mazzariello (C-suite exec) | Sold | $48.4K |
| Feb 2, 2026 | Justin B. Klee (CEO) | Sold | $228K |
| Feb 2, 2026 | Joshua B Cohen (CEO) | Sold | $228K |
| Feb 2, 2026 | James M Frates (CFO) | Sold | $52.1K |
Who's trading AMLX
- Bernhardt G Zeiher, Insider: other filings, last Jun 4, 2026
- Paul R. Fonteyne, Insider: other filings, last Jun 4, 2026
- Karen Firestone, Insider: bought $152K (2 buys), last Jun 4, 2026
- George M Milne Jr, Insider: other filings, last Jun 4, 2026
- Daphne Quimi, Insider: other filings, last Jun 4, 2026
- Joshua B Cohen, CEO: sold $2.6M (5 sales), last Mar 5, 2026
- James M Frates, CFO: sold $204K (3 sales), last Mar 5, 2026
- Camille L Bedrosian, C-suite exec: sold $189K (2 sales), last Mar 5, 2026
- Gina Mazzariello, C-suite exec: sold $198K (3 sales), last Mar 5, 2026
- Justin B. Klee, CEO: sold $2.6M (5 sales), last Mar 5, 2026
Get free alerts when an insider at Amylyx Pharmaceuticals, Inc files a new trade →